Clinical Trials Browser

Sarcoma × Granulocyte Colony-Stimulating Factor × 90 days × Clear all

NCT07602777 2026-05-22

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

Phase 1/2 Not yet recruiting

Sarcoma